Nurtec is the first oral calcitonin gene-related peptide antagonist approved for both acute and preventative treatment of migraine.
Mary Beth Seipel, PharmD, BCACP
Advertisement
Articles by Mary Beth Seipel, PharmD, BCACP
Advertisement
Latest Updated Articles
Overview of Nurtec ODT for Prevention of Episodic MigraineJanuary 4th 2022
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves XFG-Adapted COVID-19 Vaccine, mRNA for the 2026-2027 Season
2
What Heidi Overton's FDA Nomination Could Mean for Pharmacy
3
FDA Approves Bixlenvo Once-Daily Single-Tablet Regimen for Virologically Suppressed Adults With HIV
4
FDA Approves Tirzepatide to Cut CV Risk in Type 2 Diabetes
5